Clinical Trial Update: Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating photoradiation with verteporfin to enhance the immunologic activity of pembrolizumab in unresectable locally advanced or metastatic pan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Verteporfin (verteporfin)

Snippet

Sponsor: Mayo Clinic | Conditions: Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: RECRUITING